Lloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Failures
Lloyd Inc. of Iowa is recalling 3.8 million Thyro-Tab tablets due to cGMP deviations and insufficient stability data.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The source cites cGMP deviations and insufficient stability data without reporting specific injuries or illnesses, fitting the Moderate severity criteria for quality control issues.
Plain-English summary
Lloyd Inc. of Iowa is recalling 3,844,402 tablets of Lloyd Thyro-Tab 0.137 mg. The product was packaged in bulk drums for repackaging and is a prescription medication. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations. Following a quality review of stability failures in previous lots, the company determined there is insufficient data to confirm that other lots are not affected. The affected lots are HD31411 (Exp May-13) and HC04112 (Exp Aug-13).
The bulk product was distributed to Forest Laboratories, Inc. in St. Louis, MO, which repackaged the product into 100-tablet bottles. These bottles were distributed to 75 customers nationwide and in Puerto Rico. Consumers and healthcare providers should stop using the product and contact their pharmacist or physician for guidance.
The recalled product
- Product
- Lloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
- Manufacturer
- Lloyd Inc. of Iowa
- Category
- Drug — Thyroid Medication
- Affected units
- 3,844,402
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: HD31411
- Exp May-13
- HC04112
- Exp Aug-13.
Distribution
Part of a larger recall action
This product is one of 20 recalled by Lloyd Inc. of Iowa under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Lloyd Inc. of Iowa
See all →- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
Same hazard · quality control
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateDuoGlide Short-Term Dialysis Catheter recall due to deficient manufacturing
FDA (Devices) · 2026-07-08
- ModeratedirectCHECK whole blood control labeled with incorrect performance range
FDA (Devices) · 2026-06-24
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11